All Articles

Peregrine Technologies' appointment of Adrian Kaplan isn't just a new hire; it's a calculated move to mature its financial operations for global scale.

The life sciences giant beat expectations with a 60% earnings jump, raising its 2026 forecast. Key drivers include the Masimo deal and a new acquisition plan.

The Vatican's endorsement of a 'human-made' label for a new Papal text isn't a culture war footnote. It’s the birth of a new economic category.

As Nutex Health nears its Q2 results, its innovative micro-hospital empire shows impressive growth. But can it sustain a model heavily reliant on arbitration?

A new 'smart' brain implant is revolutionizing Parkinson's care in India, but as experts gather, the promise of this tech meets the reality of access.

Liberty Latin America divests its stake in Peru's WOW Telecom to América Móvil, signaling a strategic shift toward capital discipline and shareholder returns.

At AIDS 2026, ViiV Healthcare unveils data challenging treatment norms, proving long-acting injectable efficacy, and paving the way for quarterly PrEP.

Sweeping industry awards, GXS Group isn't just winning trophies; it's proving a powerful, ecosystem-led model that's reshaping finance for millions in ASEAN.

Philippine giant SM Group's 24 governance awards are more than accolades; they reveal a strategic playbook for creating lasting value amid global uncertainty.

New Victoria Hospital's leap to a cloud-based patient record system is more than a tech upgrade; it's a strategic shot in the private sector's race to redefine care.

A new platform says it can end marketing's 'decision problem,' moving beyond data overload to give one clear, prioritized action. Is this the future?

With Oaktree Capital's backing, Interblock appoints Kay Oswald as CEO to scale its global footprint and innovate in the booming electronic table gaming market.

Delectrik Systems' landmark 100 MWH vanadium flow battery project for NTPC signals a pivotal shift, boosting India's energy security and 'Made in India' goals.

As regulators crack down, the fight against financial crime is moving to real-time data. Kyckr's record growth reveals a seismic industry shift.

Mago Maga is launching its $1,598 Roma-X AI roaster on Kickstarter. Can its blend of smart tech and community features turn a niche hobby into the next big thing?

After a seven-year gauntlet, CorPower Ocean's DNV certification de-risks a long-promised technology, unlocking a new frontier for investors and the grid.

Beneath a headline-grabbing accounting loss, Heimstaden's core business is thriving. We dissect the numbers to see if operational strength trumps paper losses.

Berlin-based OMEICOS gets a major FDA boost, advancing its novel PMD drug OMT-28 directly to a pivotal Phase 3 trial. A deep dive into the science.

Mintos is offering zero-fee ETFs to millions of Europeans. We dig into whether this move will truly democratize investing or if the 'free' lunch has a hidden cost.